Oncology & Cancer

Antifolates show promise against NSCLC subtype

Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer ...

Oncology & Cancer

Scientists use worms to unearth cancer drug targets

Through novel experiments involving small nematode worms, scientists from Wyoming have discovered several genes that may be potential targets for drug development in the ongoing war against cancer. Specifically, researchers ...

Oncology & Cancer

Role of known cancer gene in ovarian cancer investigated

The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia ...

page 6 from 16